Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
A qualitative study of the childbearing experience of women living with multiple sclerosis.
Prognostic factors of acute partial transverse myelitis.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
Management of optic neuritis as a clinically first event of multiple sclerosis.
Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Silencing IFN-γ Binding/Signaling in Astrocytes versus Microglia Leads to Opposite Effects on Central Nervous System Autoimmunity.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Multiple Sclerosis: A Disease of Affluence?.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Autophagy and autoimmunity crosstalks.
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
The clinical impact of cerebellar grey matter pathology in multiple sclerosis.
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.
Does Slowed Processing Speed Account for Executive Deficits in Multiple Sclerosis? Evidence From Neuropsychological Performance and Structural Neuroimaging.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Isolation & characterization of Bartonella sp. from optic neuritis patients.

Pages